The lifelong hemorrhagic diathesis of hemophilia A is treated successfully with recombinantly derived factor VIII (rFVIII). rFVIII is presently produced and purified from mammalian cell lines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results